Nanobiotix S.A. SEC filings NNBXF
Nanobiotix S.A. has 311 filings in SEC EDGAR's recent list, going back to Dec 21, 2018. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 26, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 13, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| EFFECT | Filing | Feb 16, 2022 | — |
| CORRESP | Letter to the SEC | Feb 14, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 11, 2020 | — |
| EFFECT | Filing | Dec 10, 2020 | — |
| EFFECT | Filing | Dec 10, 2020 | — |
| CERT | 8a cert | Dec 9, 2020 | — |
| CORRESP | Letter to the SEC | Dec 8, 2020 | — |
| 8-A12B | Filing | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Dec 7, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 4, 2020 | — |
| CORRESP | Letter to the SEC | Nov 20, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 19, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2020 | — |
| DRSLTR | Filing | Oct 22, 2020 | — |
| DRS/A | Filing | Oct 22, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2020 | — |
| DRSLTR | Filing | Jun 5, 2020 | — |
| DRS/A | Filing | Jun 5, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2019 | — |
| DRSLTR | Filing | Mar 28, 2019 | — |
| DRS/A | Filing | Mar 28, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2019 | — |
| DRS | Filing | Dec 21, 2018 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NBTX (Nasdaq), NNBXF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Paris, France
- SEC filer status
- Accelerated filer
- SEC CIK
- 1760854
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.